Divergence between GLUT4 mRNA and protein abundance in skeletal muscle of insulin resistant rats

S R Hager1, D Pastorek, A L Jochen

  • 1Department of Medicine, Medical College of Wisconsin, Milwaukee 53226.

Insights

In type 2 diabetes, high blood sugar (hyperglycemia) impairs muscle glucose uptake despite normal GLUT4 protein levels. This suggests a defect in glucose transporter function or regulation, not just quantity.

Area of Science:

  • Biochemistry
  • Physiology
  • Endocrinology

Background:

  • Type 2 diabetes is characterized by hyperglycemia and skeletal muscle insulin resistance.
  • Glucose toxicity, induced by glucose infusion in rats, mimics defects in insulin action seen in type 2 diabetes.
  • Insulin resistance in these models involves post-receptor defects affecting muscle glucose uptake.

Purpose of the Study:

  • To investigate the role of the glucose transporter type 4 (GLUT4) in impaired muscle glucose uptake during hyperglycemia.
  • To determine if reduced GLUT4 mRNA or protein abundance contributes to insulin resistance in a glucose toxicity model.

Main Methods:

  • Utilized a rat model of glucose toxicity induced by glucose infusion.
  • Measured GLUT4 protein and mRNA abundance in skeletal muscle.
  • Assessed insulin-stimulated glucose uptake in skeletal muscle.

Main Results:

  • Skeletal muscle glucose uptake was reduced by 50% in hyperglycemic rats compared to controls.
  • GLUT4 protein abundance remained unchanged in hyperglycemic rats.
  • GLUT4 mRNA abundance was significantly increased (2.5-fold) in hyperglycemic rats.

Conclusions:

  • Hyperglycemia and hyperinsulinemia lead to impaired GLUT4 function or localization, not reduced expression.
  • A disconnect exists between GLUT4 mRNA levels and protein translation in this model.
  • These findings highlight post-translational regulation of GLUT4 in insulin resistance.